[1] Aarestrup F.M.,Butaye P.,Witte W.,Clewell M.S.,Courvalin D.B.,Dunny P.,Murray G.M.,Rice B.E. .2002 .The Enterococci: Nonhuman reservoirs of enterococci. In: The Enterococci: Pathogenesis, Molecular Biology and Antibiotic Resistance, : 55-99.
[2] Ahmed M.O.,Baptiste K.E. .2018 .Vancomycin-resistant enterococci: a review of antimicrobial resistance mechanisms and perspectives of human and animal health. Microbial Drug Resistance, 24 : 590-606.
[3] Arias C.A.,Murray B.E. .2012 .The rise of the Enterococcus: beyond Vancomycin resistance. Nature Reviews Microbiology, 10 : 266-278.
[4] Baureder M.,Hederstedt L. .2012 .Genes important for catalase activity in Enterococcus faecalis. PLOS ONE, 7 : e36725.
[5] Beganovic M.,Luther M.K.,Rice L.B.,Arias C.A.,Rybak M.J.,K.L. M.J. .2018 .A review of combination antimicrobial therapy for Enterococcus faecalis bloodstream infections and infective endocarditis. Clinical Infectious Diseases, 67 : 303-309.
[6] Byers K.E.,Anglim A.M.,Anneski C.J.,Germanson T.P.,Gold H.S.,Durbin L.J.,Simonton B.M.,Farr B.M. .2001 .A hospital epidemic of Vancomycin-resistant Enterococcus risk factors and control. Infection Control & Hospital Epidemiology, 22 : 140-147.
[7] Ceci M.,Delpech G.,Sparo M.,Mezzina V.,Bruni S.S.,Baldaccini B. .2015 .Clinical and microbiological features of bacteremia caused by Enterococcus faecalis. The Journal of Infection in Developing Countries, 9 : 1195-1203.
[8] Chen A.Y.,Zervos M.J.,D.L M.J. .2009 .Enterococcus: a n ti m ic r o bi a l r e sis ta n c e in E n te r oc o c c i epidemiology, treatment and control. In: Antimicrobial Drug Resistance: Clinical and Epidemiological Aspects, : 715-733.
[9] Compton S.T.,Kania S.A.,Robertson A.E.,Lawhon S.D.,Jenkins S.G.,Westblade L.F.,Bemis D.A.,Carroll K.C. .2017 .Evaluation of pyrrolidonyl arylamidase activity in Staphylococcus delphini. Journal of Clinical Microbiology, 55 : 859-864.
[10] Davani-Davari D.,Negahdaripour M.,Karimzadeh I.,Seifan M.,Mohkam M.,Masoumi S.J.,Berenjian A.,Ghasemi Y. .2019 .Prebiotics: definition, types, sources, mechanisms and clinical applications. Foods, 8 : 92.
[11] De Baere T.,Claeys G.,Verschraegen G.,Devriese L.A.,Baele M.,Van Vlem B.,Vanholder R.,Dequidt C.,Vaneechoutte M. .2000 .Continuous ambulatory peritoneal dialysis peritonitis due to Enterococcus cecorum. Journal of Clinical Microbiology, 38 : 3511-3512.
[12] de W. Blackburn C.,McClure P.J. .2009 .. Woodhead Publishing Limited and CRC, 1247 : .
[13] Dethlefsen L.,Eckburg P.B.,Bik E.M.,Relman D.A. .2006 .Assembly of the human intestinal microbiota. Trends in Ecology and Evolution, 21 : 517-523.
[14] Devriese L.,Baele M.,Butaye P.,Falkow M.,Rosenberg S.,Schleifer E.,Stackebrandt K. .2006 .The genus Enterococcus. , : 163-174.
[15] DiazGranados C.A.,Zimmer S.M.,Mitchel K.,Jernigan J.A. .2005 .Comparison of mortality associated with Vancomycin resistant and Vancomycin susceptible enterococcal bloodstream infections: a meta-analysis. Clinical Infectious Diseases, 41 : 327-333.
[16] Dieterich W.,Schink M.,Zopf Y. .2018 .Microbiota in the gastrointestinal tract. Medical Sciences, 6 : 116.
[17] Enna S.J.,Bylund D.B.,Elsevier Science .2008 .. , 16672 : .
[18] Facklam R.R.,Carvalho M.d.G.S.,Teixeira L.M.,Biology Molecular,Clewell M.S.,Courvalin D.B.,Dunny P.,Murray G.M.,Rice B.E. . .2 0 0 2 . H i s t o r y, t a x o n o m y, b i o c h e m i c a l characteristics and antibiotic susceptibility testing of Enterococci. , : 1-54.
[19] Falk P.S.,Winnike J.,Woodmansee C.,Desai M.,Mayhall C.G. .2000 .Outbreak of Vancomycinresistant Enterococci in a burn unit. Infection Control & Hospital Epidemiology, 21 : 575-582.
[20] Fiore E.,Van Tyne D.,Gilmore M.S.,Pathogens V.A.,Novick R.P.,Ferretti J.J.,Portnoy D.A.,Braunstein M.,Rood M. .2019 .Pathogenicity of Enterococci. J.I. (eds.), : 378-397.
[21] Fisher K.,Phillips C. .2009 .The ecology, epidemiology and virulence of Enterococcus. , 155 : 1749-1757.
[22] Flint H.J.,Duncan S.H.,Scott K.P.,Louis P. .2007 .Interactions and competition within the microbial community of the human colon: links between diet and health. Environmental Microbiology, 9 : 1101-1111.
[23] Flores-Mireles A.L.,Pinkner J.S.,Caparon M.G.,Hultgren S.J. .2014 .EbpA vaccine antibodies block binding of Enterococcus faecalis to fibrinogen to prevent catheter-associated bladder infection in mice. Science Translational Medicine, 6 : 254ra127-254ra127.
[24] Fridkin S.K.,Edwards J.R.,Courval J.M.,Hill H.,Tenover F.C.,Lawton R.,Gaynes R.P.,McGowan J.E. .2001 .The effect of Vancomycin and thirdgeneration cephalosporins on prevalence of Vancomycin resistant Enterococci in 126 US adult intensive care units. Annals of Internal Medicine, 135 : 175-183.
[25] Garsin D.A.,Frank K.L.,Silanpää J.,Ausubel F.M.,Hartke A.,Shankar N.,Murray B.E.,Clewell M.S.,Ike D.B.,Shankar Y.,Infirmary Ear .2014 .From Commensals to Leading Causes of Drug Resistant Infection. , : .
[26] Gilmore M.S.,Coburn P.S.,Nallapareddy S.R.,Murray B.E. .2002 .Enterococcal virulence. In: The Enterococci: Pathogenesis, Molecular Biology and Antibiotic Resistance, : 301-354.
[27] Goldman L.,Schafer A.I.,Goldman-Cecil Medicine,Scheld W.M.,Patel W.M. .2019 .Introduction to microbial disease: pathophysiology and diagnostics. Elsevier Health Sciences, Philadelphia, : 1791-1795.
[28] Gong J.,Bai T.,Zhang L.,Qian W.,Song J.,Hou X. .2017 .Inhibition effect of Bifidobacterium longum, Lactobacillus acidophilus, Streptococcus thermophilus and Enterococcus faecalis and their related products on human colonic smooth muscle in vitro. PLOS ONE, 12 : e0189257.
[29] Hidron A.I.,Edwards J.R.,Patel J.,Horan T.C.,Sievert D.M.,Pollock D.A.,Fridkin S.K. .2008 .Antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control. , 29 : 996-1011.
[30] Higuita N.I.A.,Huycke M.M.,Clewell M.S.,Ike D.B.,Shankar Y.,Infirmary Ear .2014 .Enterococci: from Commensals to Leading Causes of Drug Resistant Infection. , : .
[31] Hsueh P.,Teng P.,Chen Y.-C.,Yang Y.-C.,Ho Y.-C.,Luh Y.-C. .2000 .Recurrent bacteremic peritonitis caused by Enterococcus cecorum in a patient with liver cirrhosis. Journal of Clinical Microbiology, 38 : 2450-2452.
[32] Hughes R. .2008 .Patient Safety and Quality: An Evidence-Based Handbook for Nurses. Agency for Healthcare Research and Quality Publications, 286 : .
[33] Huycke M.M.,Biology Molecular,Clewell M.S.,Ike D.B.,Shankar Y. .2002 .Physiology of Enterococci. , : 133-175.
[34] Huycke M.M.,Abrams V.,Moore D.R. .2002 .Enterococcus faecalis produces extracellular superoxide and hydrogen peroxide that damages colonic epithelial cell DNA. Carcinogenesis, 23 : 529-536.
[35] Jafari S.,Abdollahi A.,Sabahi M.,Salehi M.,Asadollahi-Amin A.,Hasannezhad M.,Seifi A.,Disorders-Drug Targets (Formerly Current Drug Targets-Infectious Disorders A. .2022 .An update to Enterococcal bacteremia: epidemiology, resistance and outcome. , 22 : 79-85.
[36] Kampmeier S.,Tönnies H.,Correa-Martinez C.L.,Mellmann A.,Schwierzeck V. .2020 .A nosocomial cluster of Vancomycin resistant Enterococci among COVID-19 patients in an intensive care unit. Antimicrobial Resistance & Infection Control, 9 : 154.
[37] Khan Z.,Siddiqui N.,Saif M.W. .2018 .Enterococcus faecalis infective endocarditis and colorectal carcinoma: case of new association gaining ground. Gastroenterology Research, 11 : 238-240.
[38] Koch S.,Hufnagel M.,Huebner J. .2004 .Treatment and prevention of enterococcal infections-alternative and experimental approaches. Expert Opinion on Biological Therapy, 4 : 1519-1531.
[39] Leber A.L. .2016 .Bile-esculin and esculin tests. In: Clinical Microbiology Procedures Handbook, (13) : 1.
[40] Li X.,Xing J.,Li B.,Wang P.,Liu J. .2012 .Use of tuf as a target for sequence-based identification of gram-positive cocci of the genus Enterococcus, Streptococcus, coagulase-negative Staphylococcus and Lactococcus. Annals of Clinical Microbiology and Antimicrobials, 11 : 31.
[41] Linden P.,Moellering Jr,Wood R.,Rehm C.,Flaherty S.,Bompart J.,Talbot F.,G. F. .2001 .Treatment of Vancomycin resistant Enterococcus faecium infections with quinupristin/dalfopristin. , 33 : 1816-1823.
[42] Madsen K.T.,Skov M.N.,Gill S.,Kemp M. .2017 .Virulence factors associated with Enterococcus faecalis infective endocarditis: a mini review. The Open Microbiology Journal, 11 : 1.
[43] Malani P.N.,Kauffman C.A.,Zervos M.J.,Clewell M.S.,Courvalin D.B.,Dunny P.,Murray G.M.,Rice B.E. .2002 .Enterococcal disease, epidemiology and treatment. In: The Enterococci: Pathogenesis, Molecular Biology and Antibiotic Resistance, : 385-408.
[44] Murdoch D.R.,Corey G.R.,Hoen B.,Miró J.M.,Fowler V.G.,Karchmer A.S.,Olaison A.W.,Pappas L.,Moreillon P.A.,Chambers P.,Chu S.T.,Falcó V.H.,V. V.H.,Jones D.J.,Klein P.,Raymond J.L.,Read N.J.,Tripodi K.M.,Utili M.F.,Wang R.,Woods A.,Cabell C.W.,Investigators C.H.,I.C.o.E.P.C.S. C.H. .2009 .Clinical presentation, etiology and outcome of infective endocarditis in the 21st century: The international collaboration on endocarditis-prospective cohort study. Archives of Internal Medicine, 169 : 463-473.
[45] Murray P.R.,Rosenthal K.S.,Pfaller M.A.,Rosenthal P.R.,Pfaller K.S.,M.A K.S. .2020 .Streptococcus and Enterococcus. Elsevier Health Sciences, USA., : 191-209.
[46] Neish A.S. .2009 .Microbes in gastrointestinal health and disease. Gastroenterology, 136 : 65-80.
[47] Nešuta O.,Budešínský M.,Hadravová R.,Monincová L.,Humpolicková V. .2017 .How proteases from Enterococcus faecalis contribute to its resistance to short -helical antimicrobial peptides. Pathogens and Disease, 75 : 1-12.
[48] Padiglione A.A.,Wolfe R.,Grabsch E.A.,Olden D.,Pearson S.,Franklin C.,Spelman D.,Mayall B.,Johnson B.,Grayson M.L. .2003 .Risk factors for new detection of vancomycin-resistant enterococci in acute-care hospitals that employ strict infection control procedures. Antimicrobial Agents and Chemotherapy, 47 : 2492-2498.
[49] Palmer K.L.,Godfrey P.,Griggs A.,Kos V.N.,Zucker J.,Desjardins C.,Cerqueira G.,Gevers D.,Walker S.,Wortman J.,Feldgarden M.,Haas B.,Birren B.,Gilmore M.S. .2012 .Comparative genomics of enterococci: variation in Enterococcus faecalis, clade structure in E. faecium and defining characteristics of E. gallinarum and E. casseliflavus. , 3 : e00318-00311.
[50] Reid K.C.,Cockerill III,Patel F.R.,R. F.R. .2001 .Clinical and epidemiological features of Enterococcus casseliflavus/flavescens and Enterococcus gallinarum bacteremia: a report of 20 cases. , 32 : 1540-1546.
[51] Riccardi N.,Monticelli J.,Antonello R.M.,Lallo Di,Frezza G.,Luzzati D.,R. D.,Bella Di,S. Di .2021 .Therapeutic options for infections due to vanB genotype Vancomycin-resistant Enterococci. Microbial Drug Resistance, 27 : 536-545.
[52] Rowland I.,Gibson G.,Heinken A.,Scott K.,Swann J.,Thiele I.,Tuohy K. .2018 .Gut microbiota functions: metabolism of nutrients and other food components. European Journal of Nutrition, 57 : 1-24.
[53] Ryan K.J.,Ahmad N.,Alspaugh J.A.,Drew W.L.,Lagunoff M.,Pottinger P.,Reller L.B.,Reller M.E.,Sterling C.R.,Weissman S.,K.J S.,McGraw-Hill Education .2022 .Streptococci and Enterococci. , : 473-499.
[54] Said M.S.,Tirthani E.,Lesho E. .2022 .Enterococcus infections: Treasure Island (FL): StatPearls Publishing. , : .
[55] Sartingen S.,Rozdzinski E.,Muscholl-Silberhorn A.,Marre R. .2000 .Aggregation substance increases adherence and internalization, but not translocation, of Enterococcus faecalis through different intestinal epithelial cells in vitro. Infection and Immunity, 68 : 6044-6047.
[56] Sava I.G.,Heikens E.,Huebner J. .2010 .Pathogenesis and immunity in enterococcal infections. Clinical Microbiology and Infection, 16 : 533-540.
[57] Sekirov I.,Russell S.L.,Antunes L.C.M.,Finlay B.B. .2010 .Gut microbiota in health and disease. Physiological Reviews, 90 : 859-904.
[58] Shankar N.,Lockatell C.V.,Baghdayan A.S.,Drachenberg C.,Gilmore M.S.,Johnson D.E. .2001 .Role of Enterococcus faecalis surface protein Esp in the pathogenesis of ascending urinary tract infection. Infection and Immunity, 69 : 4366-4372.
[59] Stiefel U.,Paterson D.L.,Pultz N.J.,Gordon S.M.,Aron D.C.,Donskey C.J. .2004 .Effect of the increasing use of piperacillin/tazobactam on the incidence of Vancomycin resistant enterococci in four academic medical centers. Infection Control & Hospital Epidemiology, 25 : 380-383.
[60] Swidsinski A.,Loening-Baucke V.,Lochs H.,Hale L.P. .2005 .Spatial organization of bacterial flora in normal and inflamed intestine: a fluorescence in situ hybridization study in mice. World Journal of Gastroenterology, 11 : 1131.
[61] Taglialegna A.,Matilla-Cuenca L.,Dorado-Morales P.,Navarro S.,Ventura S.,Garnett J.A.,Lasa I.,Valle J. .2020 .Enterococcus faecalis forms amyloidlike fibers. NPJ Biofilms and Microbiomes, 6 : 1-12.
[62] Tannock G.W.,Cook G.,Biology Molecular,Clewell M.S.,Courvalin D.B.,Dunny P.,Murray G.M.,Rice B.E. .2002 .Enterococci as members of the intestinal microflora of humans. , : 101-132.
[63] Teixeira L.M.,Carvalho M.d.G.S.,Facklam R.R.,Shewmaker P.L.,Miller M. .2019 .Enterococcus. , : 418-435.
[64] Teixeira L.M.,Merquior V.L.C.,McKee I.,M.L I. .2013 .Enterococcus. , : 17-26.
[65] Tendolkar P.M.,Baghdayan A.S.,Gilmore M.S.,Shankar N. .2004 .Enterococcal surface protein, Esp, enhances biofilm formation by Enterococcus faecalis. Infection and Immunity, 72 : 6032.
[66] Thursby E.,Juge N. .2017 .Introduction to the human gut microbiota. Biochemical Journal, 474 : 1823-1836.
[67] Toc D.A.,Pandrea S.L.,Botan A.,Mihaila R.M.,Costache C.A.,Colosi I.A.,Junie L.M. .2022 .Enterococcus raffinosus, Enterococcus durans and Enterococcus avium isolated from a tertiary care hospital in Romania - retrospective study and brief beview. Biology, 11 : 598.
[68] Van den Berghe ,De Winter T.,De Vuyst L. .2006 .Enterocin a production by Enterococcus faecium FAIR-E 406 is characterised by a temperature-and pH-dependent switch-off mechanism when growth is limited due to nutrient depletion. International Journal of Food Microbiology, 107 : 159-170.
[69] Van Tyne D.,Martin M.J.,Gilmore M.S. .2013 .Structure, function and biology of the Enterococcus faecalis cytolysin. Toxins, 5 : 895-911.
[70] Vergis E.N.,Hayden M.K.,Chow J.W.,Snydman D.R.,Zervos M.J.,Linden P.K.,Wagener M.M.,Schmitt B.,Muder R.R. .2001 .Determinants of Vancomycin resistance and mortality rates in Enterococcal bacteremia: a prospective multicenter study. Annals of Internal Medicine, 135 : 484-492.
[71] Vergis E.N.,Shankar N.,Chow J.W.,Hayden M.K.,Snydman D.R.,Zervos M.J.,Linden P.K.,Wagener M.M.,Muder R.R. .2002 .Association between the presence of enterococcal virulence factors gelatinase, hemolysin and enterococcal surface protein and mortality among patients with bacteremia due to Enterococcus faecalis. Clinical Infectious Diseases, 35 : 570-575.
[72] Vos P.,Garrity G.,Jones D.,Krieg N.R.,Ludwig W.,Rainey F.A.,Schleifer K.H.,Whitman W.B. .2011 .Enterococcus. In: Bergey's Manual of Systematic Bacteriology, : 594-606.
[73] Vu J.,Carvalho J. .2011 .Enterococcus: review of its physiology, pathogenesis, diseases and the challenges it poses for clinical microbiology. Frontiers in Biology, 6 : 357.
[74] Wanger A.,Chavez V.,Huang R.,Wahed A.,Dasgupta A.,Actor J.K.,Elsevier Science .2017 .Molecular Diagnosis in Pathology: A Comprehensive Review for Board Preparation. Certification and Clinical Practice, : 61-73.
[75] Xu M.,Xue H.,Li X.,Zhao Y.,Lin L.,Yang L.,Zheng G. .2019 .Chemical composition, antibacterial properties and mechanism of Smilax china L. p olyp heno ls. A pp lied M icro bi o lo gy an d Biotechnology. , 103 : 9013-9022.
[76] Yilema A.,Moges F.,Tadele S.,Endris M.,Kassu A.,Abebe W.,Ayalew G. .2017 .Isolation of enterococci, their antimicrobial susceptibility patterns and associated factors among patients attending at the University of Gondar Teaching Hospital. BioMed Central Infectious Diseases, 17 : 276.
[77] Zavaryani S.M.,Mirnejad R.,Piranfar V.,Moghaddam M.M.,Sajjadi N.,Saeedi S. .2020 .Assessment of susceptibility to five common antibiotics and their resistance pattern in clinical Enterococcus isolates. Iranian Journal of Pathology, 15 : 96.